Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy
Open Access
- 23 November 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 109 (1) , 103-114
Abstract
Mammalian target of rapamycin (mTOR), a central regulator of growth and metabolism, has tissue-specific functions depending on whether it is part of mTOR complex 1 (mTORC1) or mTORC2. We have previously shown that mTORC1 is required for adaptive cardiac hypertrophy and maintenance of function under basal and pressure-overload conditions. In the present study, we aimed to identify functions of mTORC2 in the heart. Using tamoxifen-inducible cardiomyocyte-specific gene deletion, we generated mice deficient for cardiac rapamycin-insensitive companion of mTOR (rictor), an essential and specific component of mTORC2. Under basal conditions, rictor deficiency did not affect cardiac growth and function in young mice and also had no effects in adult mice. However, transverse aortic constriction caused dysfunction in the rictor-deficient hearts, whereas function was maintained in controls after 1 week of pressure overload. Adaptive increases in cardiac weight and cardiomyocyte cross-sectional area, fibrosis, and hypertrophic and metabolic gene expression were not different between the rictor-deficient and control mice. In control mice, maintained function was associated with increased protein levels of rictor, protein kinase C (PKC)βII, and PKCδ, whereas rictor ablation abolished these increases. Rictor deletion also significantly decreased PKCε at baseline and after pressure overload. Our data suggest that reduced PKCε and the inability to increase PKCβII and PKCδ abundance are, in accordance with their known function, responsible for decreased contractile performance of the rictor-deficient hearts. Our study demonstrates that mTORC2 is implicated in maintaining contractile function of the pressure-overloaded male mouse heart.Keywords
Funding Information
- the Swiss National Science Foundation (31-135559/1)
- the
- ‘Stiftung für Kardiovaskuläre Forschung Basel’
This publication has 57 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptideThe EMBO Journal, 2010
- Protein kinase Cα as a heart failure therapeutic targetJournal of Molecular and Cellular Cardiology, 2010
- Regulation of protein kinase Cδ downregulation by protein kinase Cε and mammalian target of rapamycin complex 2Cellular Signalling, 2009
- mTOR complex 2 in adipose tissue negatively controls whole-body growthProceedings of the National Academy of Sciences, 2009
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationProceedings of the National Academy of Sciences, 2008
- Spatiotemporal dynamics of lipid signaling: Protein kinase C as a paradigmIUBMB Life, 2008
- The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase CThe EMBO Journal, 2008
- Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signallingThe EMBO Journal, 2008
- Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCε and PKCδ, in adult cardiac muscle cellsJournal of Molecular and Cellular Cardiology, 2007